This platform represents an effort to synchronize phenotypic information for microbes. We have applied and collected various models, primarily Large Language Model (LLM) based, to predict phenotypes and compare these predictions to high-quality phenotypes documented in scientific literature or phenotyping studies. For each microbe, we've generated a "card" page that collects this information and illustrates how the predictions overlap with ground truth. Additionally, we provide model performance estimates for widely used public LLM models based on these high-quality data. Use the search functionality below to explore these microbe cards and compare predictions with documented phenotypes.
19163
3884
Dorea amylophila is a fascinating member of the Firmicutes phylum, primarily known for its role in the human gut microbiome. This anaerobic bacterium is particularly interesting due to its ability to ferment complex carbohydrates, especially starches, which makes it a significant player in the digestion of dietary fibers. Its name, which translates to 'starch-loving', reflects its unique metabolic capabilities that allow it to thrive in environments rich in polysaccharides. One of the most valuable aspects of Dorea amylophila is its potential contribution to gut health. By breaking down starches, it produces short-chain fatty acids (SCFAs) such as butyrate, which are known to have numerous health benefits, including anti-inflammatory properties and serving as an energy source for colonocytes. This metabolic activity positions Dorea amylophila as a key organism in the maintenance of gut homeostasis and overall health. Moreover, research into Dorea amylophila can provide insights into the interactions within the gut microbiome. Its presence and abundance can influence the composition of other microbial communities, making it a subject of interest in studies related to dysbiosis and various gastrointestinal disorders. Understanding how Dorea amylophila interacts with other gut microbes could lead to novel therapeutic strategies for managing conditions such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). In summary, Dorea amylophila stands out not only for its unique carbohydrate fermentation capabilities but also for its potential implications in human health and disease, making it a valuable organism for ongoing microbiological and biomedical research.
| Phenotype | Status |
|---|---|
| Motility | LLM-based |
| Gram staining | Literature-based |
| Aerophilicity | Literature-based |
| Extreme environment tole… | Literature-based |
| Biofilm formation | LLM-based |
| Animal pathogenicity | Literature-based |
| Biosafety level | Literature-based |
| Health association | LLM-based |
| Host association | Literature-based |
| Plant pathogenicity | Literature-based |
| Spore formation | Literature-based |
| Hemolysis | LLM-based |
| Cell shape | LLM-based |